Literature DB >> 24939054

MYC cofactors: molecular switches controlling diverse biological outcomes.

Stephen R Hann1.   

Abstract

The transcription factor MYC has fundamental roles in proliferation, apoptosis, tumorigenesis, and stem cell pluripotency. Over the last 30 years extensive information has been gathered on the numerous cofactors that interact with MYC and the target genes that are regulated by MYC as a means of understanding the molecular mechanisms controlling its diverse roles. Despite significant advances and perhaps because the amount of information learned about MYC is overwhelming, there has been little consensus on the molecular functions of MYC that mediate its critical biological roles. In this perspective, the major MYC cofactors that regulate the various transcriptional activities of MYC, including canonical and noncanonical transactivation and transcriptional repression, will be reviewed and a model of how these transcriptional mechanisms control MYC-mediated proliferation, apoptosis, and tumorigenesis will be presented. The basis of the model is that a variety of cofactors form dynamic MYC transcriptional complexes that can switch the molecular and biological functions of MYC to yield a diverse range of outcomes in a cell-type- and context-dependent fashion.
Copyright © 2014 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24939054      PMCID: PMC4143105          DOI: 10.1101/cshperspect.a014399

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  191 in total

1.  Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.

Authors:  C Bouchard; O Dittrich; A Kiermaier; K Dohmann; A Menkel; M Eilers; B Lüscher
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

2.  Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism.

Authors:  David N Boone; Ying Qi; Zhaoliang Li; Stephen R Hann
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

Review 3.  Divorcing ARF and p53: an unsettled case.

Authors:  Charles J Sherr
Journal:  Nat Rev Cancer       Date:  2006-08-17       Impact factor: 60.716

4.  Skp2 is oncogenic and overexpressed in human cancers.

Authors:  M Gstaiger; R Jordan; M Lim; C Catzavelos; J Mestan; J Slingerland; W Krek
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

5.  A SP1/MIZ1/MYCN repression complex recruits HDAC1 at the TRKA and p75NTR promoters and affects neuroblastoma malignancy by inhibiting the cell response to NGF.

Authors:  Nunzio Iraci; Daniel Diolaiti; Antonella Papa; Antonio Porro; Emanuele Valli; Samuele Gherardi; Steffi Herold; Martin Eilers; Roberto Bernardoni; Giuliano Della Valle; Giovanni Perini
Journal:  Cancer Res       Date:  2010-12-01       Impact factor: 12.701

Review 6.  The role of Sp1 and Sp3 in normal and cancer cell biology.

Authors:  Lin Li; James R Davie
Journal:  Ann Anat       Date:  2010-08-06       Impact factor: 2.698

7.  Transcriptional repression: the dark side of myc.

Authors:  Barbara Herkert; Martin Eilers
Journal:  Genes Cancer       Date:  2010-06

Review 8.  The function and regulation of the JARID1 family of histone H3 lysine 4 demethylases: the Myc connection.

Authors:  Julie Secombe; Robert N Eisenman
Journal:  Cell Cycle       Date:  2007-06-14       Impact factor: 4.534

9.  Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation.

Authors:  Zhaoliang Li; David Boone; Stephen R Hann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

10.  AP4 directly downregulates p16 and p21 to suppress senescence and mediate transformation.

Authors:  R Jackstadt; P Jung; H Hermeking
Journal:  Cell Death Dis       Date:  2013-08-15       Impact factor: 8.469

View more
  30 in total

Review 1.  An overview of MYC and its interactome.

Authors:  Maralice Conacci-Sorrell; Lisa McFerrin; Robert N Eisenman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

2.  Effects of histone deacetylase inhibitory prodrugs on epigenetic changes and DNA damage response in tumor and heart of glioblastoma xenograft.

Authors:  Nataly Tarasenko; Abraham Nudelman; Gabriela Rozic; Suzanne M Cutts; Ada Rephaeli
Journal:  Invest New Drugs       Date:  2017-03-17       Impact factor: 3.850

Review 3.  Genome recognition by MYC.

Authors:  Arianna Sabò; Bruno Amati
Journal:  Cold Spring Harb Perspect Med       Date:  2014-02-01       Impact factor: 6.915

Review 4.  Therapeutic strategies to inhibit MYC.

Authors:  Michael R McKeown; James E Bradner
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-01       Impact factor: 6.915

5.  Biophysical and Structural Methods to Study the bHLHZip Region of Human c-MYC.

Authors:  Giovanna Zinzalla
Journal:  Methods Mol Biol       Date:  2021

6.  Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma.

Authors:  Colleen T Harrington; Elena Sotillo; Aude Robert; Katharina E Hayer; Agata M Bogusz; James Psathas; Duonan Yu; Deanne Taylor; Chi V Dang; Peter S Klein; Michael D Hogarty; Birgit Geoerger; Wafik S El-Deiry; Joëlle Wiels; Andrei Thomas-Tikhonenko
Journal:  Leukemia       Date:  2019-03-26       Impact factor: 11.528

Review 7.  MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging.

Authors:  Brian C Grieb; Christine M Eischen
Journal:  Biology (Basel)       Date:  2022-06-08

8.  Loss of Nmp4 optimizes osteogenic metabolism and secretion to enhance bone quality.

Authors:  Yu Shao; Emily Wichern; Paul J Childress; Michele Adaway; Jagannath Misra; Angela Klunk; David B Burr; Ronald C Wek; Amber L Mosley; Yunlong Liu; Alexander G Robling; Nickolay Brustovetsky; James Hamilton; Kylie Jacobs; Deepak Vashishth; Keith R Stayrook; Matthew R Allen; Joseph M Wallace; Joseph P Bidwell
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-01-15       Impact factor: 4.310

Review 9.  Synthetic lethal screens as a means to understand and treat MYC-driven cancers.

Authors:  Silvia Cermelli; In Sock Jang; Brady Bernard; Carla Grandori
Journal:  Cold Spring Harb Perspect Med       Date:  2014-03-01       Impact factor: 6.915

10.  Targeted Downregulation of dMyc Suppresses Pathogenesis of Human Neuronal Tauopathies in Drosophila by Limiting Heterochromatin Relaxation and Tau Hyperphosphorylation.

Authors:  Soram Idiyasan Chanu; Surajit Sarkar
Journal:  Mol Neurobiol       Date:  2016-03-21       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.